agilon health, inc. (NYSE:AGL - Get Free Report) shares rose 3.8% on Wednesday . The stock traded as high as $2.33 and last traded at $2.32. Approximately 1,137,301 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 4,935,184 shares. The stock had previously closed at $2.23.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Sanford C. Bernstein upgraded agilon health from a "market perform" rating to an "outperform" rating and increased their price target for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. JMP Securities reiterated a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Cowen reissued a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Stifel Nicolaus raised their price target on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group lifted their price objective on shares of agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, agilon health has an average rating of "Hold" and an average target price of $4.79.
View Our Latest Stock Analysis on AGL
agilon health Stock Up 1.6%
The stock has a market capitalization of $933.46 million, a PE ratio of -2.40 and a beta of 0.38. The business has a 50 day moving average of $3.79 and a two-hundred day moving average of $3.19. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.
agilon health (NYSE:AGL - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the prior year, the company posted ($0.02) earnings per share. agilon health's revenue for the quarter was down 4.5% compared to the same quarter last year. Analysts predict that agilon health, inc. will post -0.59 EPS for the current year.
Institutional Investors Weigh In On agilon health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Ieq Capital LLC acquired a new position in shares of agilon health during the fourth quarter valued at about $26,000. Signaturefd LLC lifted its stake in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after buying an additional 8,467 shares during the period. Humankind Investments LLC purchased a new stake in shares of agilon health during the fourth quarter valued at $30,000. Raymond James Financial Inc. acquired a new position in shares of agilon health in the 4th quarter valued at $33,000. Finally, Cerity Partners LLC acquired a new position in shares of agilon health in the 4th quarter valued at $34,000.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.